Conflict of interest: Nothing to declare.
Outcome of pediatric patients with acute myeloid leukemia (AML) and −5/5q− abnormalities from five pediatric AML treatment protocols: A report from the Children's Oncology Group
Article first published online: 30 AUG 2013
© 2013 Wiley Periodicals, Inc.
Pediatric Blood & Cancer
Volume 60, Issue 12, pages 2073–2078, December 2013
How to Cite
Johnston, D. L., Alonzo, T. A., Gerbing, R. B., Hirsch, B., Heerema, N. A., Ravindranath, Y., Woods, W. G., Lange, B. J., Gamis, A. S. and Raimondi, S. C. (2013), Outcome of pediatric patients with acute myeloid leukemia (AML) and −5/5q− abnormalities from five pediatric AML treatment protocols: A report from the Children's Oncology Group. Pediatr. Blood Cancer, 60: 2073–2078. doi: 10.1002/pbc.24573
- Issue published online: 8 OCT 2013
- Article first published online: 30 AUG 2013
- Manuscript Accepted: 28 MAR 2013
- Manuscript Received: 22 JAN 2013
Additional supporting information may be found in the online version of this article at the publisher's web-site.
|pbc24573-sm-0001-SupTable-SI.docx||31K||Table SI. Overall Survival and Event Free Survival by Study.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.